Relieve A Pain

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Relieve A Pain
Generic name: LIDOCAINE
Manufacturer: Relieve A Pain LLC
Product type: HUMAN OTC DRUG
SPL set ID: cafaa830-d894-4590-8928-d579cc791d79
SPL ID: 47e4cccd-ac00-efb8-e063-6294a90a64ce
Version: 1
Effective date: 2026-01-08
Source export date: 2026-09-28
Source partition: 3
Source file: https://download.open.fda.gov/drug/label/drug-label-0003-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/fd09911bd1bc81f7f2faeb048e63855fe224e494376ae919a0035190e315c050/drug-label-0003-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:18:55

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 10 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M017	openfda.application_number
brand name		Relieve A Pain	openfda.brand_name
generic name		LIDOCAINE	openfda.generic_name
manufacturer name		Relieve A Pain LLC	openfda.manufacturer_name
ndc	package	87198-001-01	openfda.package_ndc
ndc	product	87198-001	openfda.product_ndc
ndc11	package	87198000101	derived:openfda.package_ndc
spl id		47e4cccd-ac00-efb8-e063-6294a90a64ce	id
spl set id		cafaa830-d894-4590-8928-d579cc791d79	set_id
unii		98PI200987	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only Avoid contact with eyes Do not use in large quantities, particularly over raw surfaces or blistered areas. Discontinue use and consult a doctor if • Condition worsens, or if symptoms persist for more than 7 days or clear up and occur again within a few days. Keep out of reach of children • If the product is swallowed, get medical help or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.